Zoetis Inc. Shares Outstanding (Cover Page)
Zoetis Inc. (ZTS) had Shares Outstanding (Cover Page) of 413.22 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 413.22M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 419.23M shares.
- 2026-02-06: Entity Common Stock, Shares Outstanding 422.13M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 440.69M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-07-31 | 413.22M shares 10-Q · filed 2026-08-06 | |
| 2026-05-01 | 419.23M shares 10-Q · filed 2026-05-07 | |
| 2026-02-06 | 422.13M shares 10-K · filed 2026-02-12 | |
| 2025-10-31 | 440.69M shares 10-Q · filed 2025-11-04 | |
| 2025-08-01 | 443.18M shares 10-Q · filed 2025-08-05 | |
| 2025-05-02 | 445.21M shares 10-Q · filed 2025-05-06 | |
| 2025-02-07 | 447.79M shares 10-K · filed 2025-02-13 | |
| 2024-10-31 | 451.17M shares 10-Q · filed 2024-11-04 | |
| 2024-08-02 | 453.05M shares 10-Q · filed 2024-08-06 | |
| 2024-04-26 | 456.30M shares 10-Q · filed 2024-05-02 | |
| 2024-02-09 | 457.87M shares 10-K · filed 2024-02-13 | |
| 2023-10-27 | 459.11M shares 10-Q · filed 2023-11-02 | |
| 2023-08-04 | 460.32M shares 10-Q · filed 2023-08-08 | |
| 2023-04-28 | 462.11M shares 10-Q · filed 2023-05-04 | |
| 2023-02-10 | 463.39M shares 10-K · filed 2023-02-14 | |
| 2022-10-28 | 466.07M shares 10-Q · filed 2022-11-03 | |
| 2022-07-29 | 468.14M shares 10-Q · filed 2022-08-04 | |
| 2022-04-29 | 470.63M shares 10-Q · filed 2022-05-05 | |
| 2022-02-11 | 471.97M shares 10-K · filed 2022-02-15 | |
| 2021-10-29 | 473.13M shares 10-Q · filed 2021-11-04 | |
| 2021-07-30 | 473.94M shares 10-Q · filed 2021-08-05 | |
| 2021-04-30 | 474.77M shares 10-Q · filed 2021-05-06 | |
| 2021-02-11 | 475.17M shares 10-K · filed 2021-02-16 | |
| 2020-10-30 | 475.27M shares 10-Q · filed 2020-11-05 | |
| 2020-07-31 | 475.14M shares 10-Q · filed 2020-08-06 | |
| 2020-05-01 | 474.94M shares 10-Q · filed 2020-05-06 | |
| 2020-02-07 | 474.93M shares 10-K · filed 2020-02-13 | |
| 2019-11-01 | 476.30M shares 10-Q · filed 2019-11-07 | |
| 2019-08-02 | 477.56M shares 10-Q/A · filed 2019-08-09 | 24.33M shares 10-Q · filed 2019-08-06 |
| 2019-04-26 | 478.66M shares 10-Q · filed 2019-05-02 | |
| 2019-02-08 | 478.77M shares 10-K · filed 2019-02-14 | |
| 2018-10-26 | 480.45M shares 10-Q · filed 2018-11-01 | |
| 2018-07-27 | 481.82M shares 10-Q · filed 2018-08-02 | |
| 2018-04-27 | 483.87M shares 10-Q · filed 2018-05-02 | |
| 2018-02-09 | 485.25M shares 10-K · filed 2018-02-15 | |
| 2017-10-26 | 487.29M shares 10-Q · filed 2017-11-02 | |
| 2017-08-02 | 489.11M shares 10-Q · filed 2017-08-08 | |
| 2017-04-28 | 490.80M shares 10-Q · filed 2017-05-04 | |
| 2017-02-10 | 491.96M shares 10-K · filed 2017-02-16 | |
| 2016-10-31 | 493.83M shares 10-Q · filed 2016-11-03 | |
| 2016-08-01 | 495.04M shares 10-Q · filed 2016-08-05 | |
| 2016-04-29 | 496.20M shares 10-Q · filed 2016-05-06 | |
| 2016-02-19 | 497.16M shares 10-K · filed 2016-02-24 | |
| 2015-11-02 | 497.92M shares 10-Q · filed 2015-11-05 | |
| 2015-08-03 | 498.94M shares 10-Q · filed 2015-08-06 | |
| 2015-05-01 | 499.96M shares 10-Q · filed 2015-05-07 | |
| 2015-02-23 | 500.79M shares 10-K · filed 2015-02-27 | |
| 2014-11-07 | 501.32M shares 10-Q · filed 2014-11-10 | |
| 2014-08-08 | 501.19M shares 10-Q · filed 2014-08-12 | |
| 2014-05-09 | 501.02M shares 10-Q · filed 2014-05-13 | |
| 2014-03-19 | 500.73M shares 10-K · filed 2014-03-26 | |
| 2013-11-08 | 500.01M shares 10-Q · filed 2013-11-13 | |
| 2013-08-09 | 500.00M shares 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |